AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22329791 — intervention group
Group type: COMPARATOR
Intervention: Novel pairs (HOST-VASE)
Number of subjects: 0
Study 20489741 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-light soft magnetic field laser stimulation of conception vessel 24 (CV 24) for 1 min
Number of subjects: 45
Study 20489741 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of laser stimulation of CV 24 and acupressure pericardium 6 (PC 6)
Number of subjects: 45
Study 20489741 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (no active intervention)
Number of subjects: 45
Study 18412759 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase (F)
Number of subjects: 202
Study 18412759 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase (L)
Number of subjects: 202
Study 15750042 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg twice daily for 4 weeks, then 50 mg three times daily)
Number of subjects: 26
Study 15750042 — intervention group
Group type: COMPARATOR
Intervention: Bosentan (62.5 mg twice daily for 4 weeks, then 125 mg twice daily)
Number of subjects: 26
Study 12390634 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 61847
Study 10499226 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT‐based workshop
Number of subjects: 88
Study 10499226 — intervention group
Group type: COMPARATOR
Intervention: Didactic workshop
Number of subjects: 88
Study 8544280 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4.0-5.5 micrograms.kg‐1 orally 90 minutes before surgery
Number of subjects: 16
Study 8544280 — intervention group
Group type: COMPARATOR
Intervention: No premedication (Control group)
Number of subjects: 16
Study 8544280 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine group
Number of subjects: 16
Study 8544280 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 1749871 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of isosorbide dinitrate sustained release (ISDN-SR) four times daily
Number of subjects: 11
Study 1749871 — intervention group
Group type: COMPARATOR
Intervention: 40 mg of isosorbide dinitrate sustained release (ISDN-SR) twice daily
Number of subjects: 11
Study 1749871 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of 20 mg four times daily vs 40 mg twice daily
Number of subjects: 11
Study 1749871 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosage regimens
Number of subjects: 11
Study 30785379 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care for the Reduction of Secondary Stroke (ICARUSS) model
Number of subjects: 249
Study 30785379 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 249
Study 31167023 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS treatment
Number of subjects: 121
Study 31167023 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment
Number of subjects: 121
Study 31167023 — intervention group
Group type: COMPARATOR
Intervention: Baseline MDD vs Healthy Controls
Number of subjects: 121
Study 27927938 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mA cathodal tDCS over the contralesional primary motor cortex for 20 minutes during daily therapy
Number of subjects: 24
Study 27927938 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 24
Study 26271200 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 0
Study 26271200 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 0
Study 24136267 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal invasive internal fixation with U-shaped break-off pedicle screws (Group A)
Number of subjects: 40
Study 24136267 — intervention group
Group type: COMPARATOR
Intervention: Traditional posterior midline approach and open procedure (Group B)
Number of subjects: 40
Study 21422768 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (E-EPA) 1 g/day
Number of subjects: 25
Study 21422768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 19968409 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 116
Study 19968409 — intervention group
Group type: COMPARATOR
Intervention: No-alcohol control beverage
Number of subjects: 116
Study 16897990 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (80 mg/m2/day for 4 weeks followed by 2 weeks rest for a year)
Number of subjects: 800
Study 16897990 — intervention group
Group type: COMPARATOR
Intervention: UFT (400 mg/m2/day for 5 days followed by 2 days rest for a year)
Number of subjects: 800
Study 15163474 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg + Zn (200 mg Mg and 30 mg Zn)
Number of subjects: 69
Study 15163474 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins C + E (200 mg Vitamin C and 150 mg Vitamin E)
Number of subjects: 69
Study 15163474 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Mg + Zn and Vitamins C + E
Number of subjects: 69
Study 15163474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 11339401 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapor-cut
Number of subjects: 100
Study 11339401 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 100
Study 9159306 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual MAP goal of 102 to 107 mm Hg
Number of subjects: 94
Study 9159306 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blocker regimen (amlodipine)
Number of subjects: 94
Study 9159306 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker regimen (atenolol)
Number of subjects: 94
Study 9159306 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor regimen (enalapril)
Number of subjects: 94
Study 9159306 — intervention group
Group type: COMPARATOR
Intervention: Low MAP goal of < or = 92 mm Hg
Number of subjects: 94
Study 7965632 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsphere assay
Number of subjects: 69
Study 7965632 — intervention group
Group type: COMPARATOR
Intervention: Flow cytometry
Number of subjects: 69
Study 7965632 — intervention group
Group type: COMPARATOR
Intervention: Immunofluorescence microscopy
Number of subjects: 69
Study 3309430 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol during 30-60 W exercise
Number of subjects: 16
Study 3309430 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol during 90 W exercise
Number of subjects: 16
Study 3309430 — intervention group
Group type: COMPARATOR
Intervention: Control bicycle-ergometric test
Number of subjects: 16
Study 31711513 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous adipose-derived stromal cells (ASCs)
Number of subjects: 60
Study 31711513 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 60
Study 27702823 — intervention group
Group type: COMPARATOR
Intervention: Cabazitaxel 25 mg/m2 every 3 weeks plus prednisone 10 mg/day (group CABA)
Number of subjects: 246
Study 27702823 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel 25 mg/m2 every 3 weeks with concomitant budesonide 9 mg daily during the first two treatment cycles (group BUD)
Number of subjects: 246
Study 27702823 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CABA and BUD)
Number of subjects: 246
Study 26222846 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild caloric restriction during a 3 to 6-day hospitalization
Number of subjects: 10
Study 23802920 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-volume sprint interval training (SIT) - 6 sessions of 8-12 x 10s sprints
Number of subjects: 16
Study 23802920 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise recommendations (TER) - 10 sessions of 30 min at 65% peak oxygen consumption (VO(2peak))
Number of subjects: 16
Study 21783046 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 54
Study 19539073 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents in diabetic patients
Number of subjects: 7492
Study 19539073 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents in nondiabetic patients
Number of subjects: 7492
Study 16306998 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg o.d.
Number of subjects: 160
Study 16306998 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril 20 mg/HCTZ 12.5 mg o.d.
Number of subjects: 160
Study 14551698 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Number of subjects: 0
Study 11055772 — intervention group
Group type: EXPERIMENTAL
Intervention: Betula 30c tablets
Number of subjects: 66
Study 11055772 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 66
Study 9463204 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative corticoid treatment (CC)
Number of subjects: 46
Study 9463204 — intervention group
Group type: COMPARATOR
Intervention: No perioperative corticoid treatment (NCC)
Number of subjects: 46
Study 8382291 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable implants
Number of subjects: 43
Study 8382291 — intervention group
Group type: COMPARATOR
Intervention: Steel implants
Number of subjects: 43
Study 3486551 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-run outpatient hypertension clinics
Number of subjects: 2806
Study 3486551 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 2806
Study 31605641 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intervention (education + professional cleaning)
Number of subjects: 104
Study 31605641 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention
Number of subjects: 104
Study 31605641 — intervention group
Group type: EXPERIMENTAL
Intervention: Dust endotoxin load reduction
Number of subjects: 104
Study 28651588 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Information Technology (HIT) home monitoring
Number of subjects: 21
Study 25226328 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage treatment for 15 minutes by physiotherapist, consisting of light stroking, milking, friction, and skin rolling.
Number of subjects: 21
Study 25226328 — intervention group
Group type: COMPARATOR
Intervention: Control group (EIMD-treated without massage).
Number of subjects: 21
Study 23617607 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Spaced Education (SE) programme
Number of subjects: 97
Study 23617607 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SE programme)
Number of subjects: 97
Study 21570904 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric force task (torque rise time and force variability)
Number of subjects: 24
Study 21570904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined measures across force and movement tasks (force variability and peak deceleration)
Number of subjects: 24
Study 19926058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 19926058 — intervention group
Group type: COMPARATOR
Intervention: Usual-dose sirolimus (8 mg cumulative loading dose, 2 mg/day for 7 days)
Number of subjects: 300
Study 19926058 — intervention group
Group type: COMPARATOR
Intervention: High-dose sirolimus (24 mg cumulative loading dose, 2 mg/day for 7 days)
Number of subjects: 300
Study 19926058 — intervention group
Group type: COMPARATOR
Intervention: Usual-dose sirolimus
Number of subjects: 300
Study 19926058 — intervention group
Group type: COMPARATOR
Intervention: High-dose sirolimus
Number of subjects: 300
Study 17225518 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil combined with propofol anesthesia
Number of subjects: 30
Study 17225518 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl combined with propofol anesthesia
Number of subjects: 30
Study 15513312 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (ISO)
Number of subjects: 34
Study 15513312 — intervention group
Group type: COMPARATOR
Intervention: Control group (no isoflurane)
Number of subjects: 34
Study 11811506 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration (GTR) with bioabsorbable membrane
Number of subjects: 112
Study 11811506 — intervention group
Group type: COMPARATOR
Intervention: Control group (access flap alone)
Number of subjects: 112
Study 9581180 — intervention group
Group type: EXPERIMENTAL
Intervention: Positioning support cushion
Number of subjects: 55
Study 9581180 — intervention group
Group type: COMPARATOR
Intervention: No positioning support cushion
Number of subjects: 55
Study 7974549 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training for NIH Stroke Scale
Number of subjects: 162
Study 2478778 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermally delivered nitroglycerin (NTG 10 mg/24 h)
Number of subjects: 11
Study 2478778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1101755 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 50
Study 1101755 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 50
Study 29093005 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV pp65-specific T cells with CMV-DC vaccination (CMV-ATCT-DC)
Number of subjects: 17
Study 29093005 — intervention group
Group type: COMPARATOR
Intervention: Saline (CMV-ATCT-saline)
Number of subjects: 17
Study 27058689 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium Laser Bladder Neck Incision (HoBNI)
Number of subjects: 140
Study 27058689 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bladder Neck Incision (C-BNI)
Number of subjects: 140
Study 25636822 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy-driven intervention to improve sun safety behaviour
Number of subjects: 20
Study 25636822 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of sunscreen utilized by Year 6 classes
Number of subjects: 20
Study 23221623 — intervention group
Group type: EXPERIMENTAL
Intervention: Active anodal transcranial direct current stimulation (tDCS)
Number of subjects: 8
Study 23221623 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 8
Study 20439952 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorine
Number of subjects: 126
Study 20439952 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa oleifera seeds
Number of subjects: 126
Study 20439952 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed valved container
Number of subjects: 126
Study 20439952 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 126
Study 18192906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclosporin A (CsA) dosage reduction
Number of subjects: 40
Study 18192906 — intervention group
Group type: COMPARATOR
Intervention: Control group (stable CsA dose)
Number of subjects: 40
Study 17171330 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen implant (CMI) with high tibial valgus osteotomy
Number of subjects: 60
Study 17171330 — intervention group
Group type: COMPARATOR
Intervention: Correction only (valgization correction osteotomy)
Number of subjects: 60
Study 12704306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation and cervical extension-compression traction (vertical weight applied to the subject's forehead in the sitting position with a transverse load at the area of kyphosis)
Number of subjects: 30
Study 12704306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 10748957 — intervention group
Group type: EXPERIMENTAL
Intervention: Moist Exposed Burn Ointment (MEBO)
Number of subjects: 39
Study 10748957 — intervention group
Group type: COMPARATOR
Intervention: Silver Sulphadiazine
Number of subjects: 39
Study 9364618 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (VP) 40 IU for three months
Number of subjects: 26
Study 9364618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 1604262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PEMT collars
Number of subjects: 40
Study 1604262 — intervention group
Group type: COMPARATOR
Intervention: Facsimile (placebo)
Number of subjects: 40
Study 3890394 — intervention group
Group type: EXPERIMENTAL
Intervention: muzolimine (20 mg o.d.)
Number of subjects: 49
Study 3890394 — intervention group
Group type: COMPARATOR
Intervention: acebutolol (400 mg o.d.)
Number of subjects: 49
Study 29197947 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted dialectical behavior therapy (DBT) skills training for 10 sessions
Number of subjects: 31
Study 29197947 — intervention group
Group type: COMPARATOR
Intervention: Waiting list comparison condition (control)
Number of subjects: 31
Study 30439812 — intervention group
Group type: EXPERIMENTAL
Intervention: D + ASA (Duloxetine + Acetylsalicylic Acid 100 mg)
Number of subjects: 40
Study 30439812 — intervention group
Group type: COMPARATOR
Intervention: E + placebo (Escitalopram + Placebo)
Number of subjects: 40
Study 30439812 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance (measured by HAQ)
Number of subjects: 40
Study 27029487 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (20 mg/kg/day)
Number of subjects: 5
Study 24908096 — intervention group
Group type: EXPERIMENTAL
Intervention: Lee Silverman voice treatment (16 sessions of 50-60 minutes over four weeks with extra home practice)
Number of subjects: 60
Study 24908096 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard speech and language therapy (dose determined by individual needs, not exceeding eight weeks of treatment)
Number of subjects: 60
Study 24908096 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care with no speech and language therapy input for at least six months post-randomization)
Number of subjects: 60
Study 23445512 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed sleep timing and increased sleepiness (ESS)
Number of subjects: 24
Study 23445512 — intervention group
Group type: COMPARATOR
Intervention: Combined subtypes of ADHD
Number of subjects: 24
Study 23445512 — intervention group
Group type: EXPERIMENTAL
Intervention: Inattentive subtypes of ADHD
Number of subjects: 24
Study 23445512 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-controlled participants
Number of subjects: 24
Study 19769599 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aripiprazole adjunctive to antidepressant treatment (ADT)
Number of subjects: 186
Study 20307427 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-oxide impregnated socks
Number of subjects: 56
Study 16704570 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TV viewing
Number of subjects: 321
Study 16704570 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive TV exposure
Number of subjects: 321
Study 16704570 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing adult-targeted TV programs
Number of subjects: 321
Study 16704570 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds ratios for passive TV exposure
Number of subjects: 321
Study 16704570 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds ratios for viewing adult-targeted programs
Number of subjects: 321
Study 12796831 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron 8 mg twice daily for seven days
Number of subjects: 45
Study 12796831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10857839 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol with systemic beta-blockers
Number of subjects: 926
Study 10857839 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine with systemic beta-blockers
Number of subjects: 926
Study 10857839 — intervention group
Group type: COMPARATOR
Intervention: Timolol without systemic beta-blockers
Number of subjects: 926
Study 10857839 — intervention group
Group type: COMPARATOR
Intervention: Brimonidine without systemic beta-blockers
Number of subjects: 926
Study 8775104 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 8775104 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 0
Study 8775104 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O)
Number of subjects: 0
Study 8775104 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane and Sevoflurane (up to 1.0 MAC)
Number of subjects: 0
Study 8775104 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane vs Sevoflurane
Number of subjects: 0
Study 1615175 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification (30 min) followed by postural drainage (20 min) with forced expiration technique
Number of subjects: 7
Study 1615175 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 7
Study 3091468 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 10
Study 3091468 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ranitidine
Number of subjects: 10
Study 3091468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30517283 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal silicone splint (intervention)
Number of subjects: 7
Study 27087019 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging-guided LV lead placement using cardiac CT venography, 99m Technetium myocardial perfusion imaging, and speckle-tracking echocardiography
Number of subjects: 182
Study 27087019 — intervention group
Group type: COMPARATOR
Intervention: Routine LV lead implantation in a posterolateral region with late electrical activation
Number of subjects: 182
Study 27087019 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging-guided LV lead placement
Number of subjects: 182
Study 27087019 — intervention group
Group type: COMPARATOR
Intervention: Routine LV lead implantation
Number of subjects: 182
Study 24854306 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH stimulation test with 250 μg of synthetic ACTH administered intravenously on Days 1, 2, 3, 5, and 7 after traumatic injury
Number of subjects: 70
Study 24854306 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRCI patients with Δcortisol < 9 μg/dL
Number of subjects: 70
Study 24854306 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRCI patients
Number of subjects: 70
Study 24854306 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRCI diagnosis
Number of subjects: 70
Study 24854306 — intervention group
Group type: EXPERIMENTAL
Intervention: Δcortisol < 9 μg/dL
Number of subjects: 70
Study 23687218 — intervention group
Group type: EXPERIMENTAL
Intervention: Viofor JPS Classic device (pulsed electromagnetic field with low induction of ELF range)
Number of subjects: 84